Drug development – Biasly

Drug development Follow

Investors want proof AI will aid drug discovery. Evidence may come in the second half

Drug development

Investors want proof AI will aid drug discovery. Evidence may come in the second half

CNBC
Jul 06, 2024

Center

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development - Centogene (NASDAQ:CNTG)

Neurodegenerative disease

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development - Centogene (NASDAQ:CNTG)

Benzinga
Jun 20, 2024

Center

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

Neurodegenerative disease

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

Eagle-Tribune
Jun 20, 2024

Center

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development By Investing.com

Drug development

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development By Investing.com

Investing
Jun 20, 2024

Center

The use of artificial intelligence in life sciences: recent developments and guiding principles

Biotechnology

The use of artificial intelligence in life sciences: recent developments and guiding principles

Lexology
Jul 21, 2023

Medium Liberal

Merck sues over law empowering Medicare to negotiate with drug makers - The Boston Globe

Medicare (United States)

Merck sues over law empowering Medicare to negotiate with drug makers - The Boston Globe

The Boston Globe
Jun 06, 2023

Somewhat Liberal